During the 2007 Annual Meeting of the American Academy of Ophthalmology in New Orleans, LA, NeoVista, Inc. provided new data from a one-year feasibili...
Here's a bit of encouraging news for patients afflicted with the brain tumor known as glioblastoma multiforme (GBM):U.S. biotechnology company Genente...
Again, using briefs supplied by Ophthalmology Times and Ocular Surgery News, here are some additional highlights from the Retina 2007 Subspecialty Day...
Again, using briefs supplied by Ophthalmology Times and Ocular Surgery News, here are the highlights from the second day of the Retina 2007 Subspecial...
I have received brief writeups from both Ophthalmology Times and Ocular Surgery News covering the first day of the Retina 2007 Subspecialty Day presen...
On the eve of the American Academy of Ophthalmology meeting in New Orleans, scheduled to begin tomorrow (November 9-14), the Center for Preventative O...
Bevacizumab is a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels.Now, a new study found t...
As reported this morning on the WSJ Health Blog, Genentech has rescinded its declaration to stop supplying Avastin to compounding pharmacies as of Nov...